DURLOBACTAM-SULBACTAM
Added to formulary February 2025 with restriction to infectious disease for the treatment of culture identified carbapenem resistant Acinetobacter bumannii hospital-acquired and ventilator-acquired pneumonia.
Added to formulary February 2025 with restriction to infectious disease for the treatment of culture identified carbapenem resistant Acinetobacter bumannii hospital-acquired and ventilator-acquired pneumonia.